http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2593785-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cee6c6718e63bac2607267caf5105e54 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 |
filingDate | 2014-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a20255871888e5097e04221f05a33d95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a3994acb6d356d5f1d4b0cebdc01ab4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d907b3e47d5f5f68136e7d87f2e1cf |
publicationDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2593785-C2 |
titleOfInvention | Method of maturated liver residual cavity treating after echinococcectomy |
abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine and aims at treating maturated liver residual cavity after echinococcectomy. Residual liver cavity is treated with "Bemetrim" preparation consisting of (g/100 ml): pepsin powder 4.0-4.5 g; betaine hydrochloride 4.0-4.5 g; methyluracil 3.0-4.0 g; trimecaine 2.0-3.0 g; polyethylene oxide 400 87.0-84.0 ml. First stage is washing residual cavity through drainage tube with micro irrigator with usual antiseptic solution. Then "Bemetrim" preparation is introduced in amount of 2/3 of residual cavity volume and drain tube and micro irrigator are closed for 2 h. Through 2 hours evacuation of residual cavity contents by suction is performed. Therapeutic course is 1 procedure a day, 15±1.0 day. n EFFECT: method provides increase in active surface of action and, as result, effective penetration of antiseptic in folds of residual cavity without injuring walls of fibrous capsule, has necrolytic, bactericidal, local anesthetic, draining, cytoprotective, buffer, stimulating regeneration effect and provides higher clinical effectiveness. n 1 cl, 2 ex |
priorityDate | 2014-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 212.